BPL-003 clinical trials

An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression

This study is looking at a new nasal spray called BPL-003 for people with depression that hasn't responded to other treatments. It will check if it's safe, how well it's tolerated, and how it affects the body, either alone or with common antidepressants.